Hasegawa K, Yukioka H, Hayashi M, Tatekawa S, Fujimori M
Department of Anesthesiology and Intensive Care Medicine, Osaka City University Medical School, Japan.
Acta Anaesthesiol Scand. 1996 Apr;40(4):489-95. doi: 10.1111/j.1399-6576.1996.tb04474.x.
Lidocaine has been shown to accumulate in the lung following its administration. This study was undertaken to determine effects of dose of lidocaine on lung uptake during hyperoxic and hypoxic ventilation.
Using cross-circulation of ventilation and constant-flow perfusion of the left lower lobe independently from all other lobes of the dog lung under nitrous oxide and halothane anesthesia, lidocaine was infused into the inflow system, so that plasma lidocaine concentrations in the inflow blood were maintained at 5, 10, 20, 40 and 70 micrograms/ml respectively during ventilation with 50% O2 or 3% O2. During 20 micrograms/ml lidocaine infusion, indocyanine green (ICG), an intravascular marker, was mixed with the lidocaine solution, in such a fashion that plasma ICG concentration in the inflow blood was maintained at 20 micrograms/ml. Actual plasma lidocaine and ICG concentrations in blood drawn from the inflow ([Lid]pa,[ICG]pa) and the outflow ([Lid]pv,[ICG]pv)systems were measured, 1, 3, 5, 7 and 10 minutes after the beginning of lidocaine infusion. Percent lung uptake of perfused lidocaine was calculated as ¿1-([Lid]pv/[Lid]pa)/([ICG]pv/[ICG]pa)¿ x 100.
During ventilation hyperoxia, mean percent lung uptakes of lidocaine were 41-52% 1 minute after the beginning of lidocaine infusion, and decreased in time-dependent fashion to 7-12% 10 minutes later. Curves of percent lung uptake of lidocaine over time were similar for the 5 predetermined lidocaine concentration groups (5-70 micrograms/ml). There were no significant differences in percent lung uptakes of lidocaine between the ventilation hyperoxia and hypoxia conditions.
These findings suggest that percent lung uptake of lidocaine is unaffected by hypoxic ventilation and by varying the concentration of lidocaine in the perfusion through the recipient dog lung lobe.
利多卡因给药后会在肺中蓄积。本研究旨在确定利多卡因剂量对高氧和低氧通气期间肺摄取的影响。
在氧化亚氮和氟烷麻醉下,利用犬肺左下叶独立于其他所有肺叶的通气交叉循环和恒流灌注,将利多卡因注入流入系统,使得在50%氧气或3%氧气通气期间,流入血液中的血浆利多卡因浓度分别维持在5、10、20、40和70微克/毫升。在输注20微克/毫升利多卡因期间,将血管内标记物吲哚菁绿(ICG)与利多卡因溶液混合,以使流入血液中的血浆ICG浓度维持在20微克/毫升。在利多卡因输注开始后1、3、5、7和10分钟,测量从流入([Lid]pa,[ICG]pa)和流出([Lid]pv,[ICG]pv)系统抽取的血液中实际的血浆利多卡因和ICG浓度。灌注利多卡因的肺摄取百分比计算为 ¿1 - ([Lid]pv / [Lid]pa) / ([ICG]pv / [ICG]pa)¿ × 100。
在高氧通气期间,利多卡因输注开始后1分钟,肺摄取利多卡因的平均百分比为41 - 52%,并随时间呈下降趋势,10分钟后降至7 - 12%。5个预定利多卡因浓度组(5 - 70微克/毫升)的利多卡因肺摄取百分比随时间变化的曲线相似。高氧通气和低氧通气条件下利多卡因的肺摄取百分比无显著差异。
这些发现表明,利多卡因的肺摄取百分比不受低氧通气以及受体犬肺叶灌注中利多卡因浓度变化的影响。